Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Free Cash Flow history
Currency unavailable · from the cash flow
No Free Cash Flow data reported for this period type.
Free Cash Flow vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $580.71M USD | +31.8% | +19.8% | 818.4% | |
| LTM Jun 2026 | $143.72M USD | +15.6% | — | 2018.3% | |
| LTM Mar 2026 | $64.63M USD | -24.7% | -18.0% | 28725.3% | |
| FY2025 | $42.57M USD | — | — | 228.7% | |
| LTM Mar 2026 | $36.19M USD | +86.7% | +16.5% | — | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +23.7% | +16.5% | 1418.3% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.